Safety and Efficacy Study of reSept ASD Occluder for Treating Secundum ASD
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Thomas Forbes, MD
Joe DiMaggio Children's Hospital/Memorial Healthcare
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
32 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Toronto General Hospital
Toronto, Canada
- Hôpital Cardiologique Haut-Leveque (chu Bordeaux)
Bordeaux, France
- Service de Cardiologie Pédiatrique Et Congénitale
Lille, France
- Hôpital Mere Enfants (chu Nantes)
Nantes, France
- Hôpital Necker Enfants Malades
Paris, France
- Hôpital Des Enfants (chu Toulouse)
Toulouse, France
- Centre Hospitalier Universitaire Vaudois (chuv)
Lausanne, Switzerland
- University Children'S Hospital Zurich
Zurich, Switzerland
- University of Alabama at Birmingham
Birmingham, Alabama, United States
- Children'S Hospital of Los Angeles
Los Angeles, California, United States
- Los Robles Regional Medical Center
Thousand Oaks, California, United States
- Children'S Hospital Colorado
Aurora, Colorado, United States
- Yale University
New Haven, Connecticut, United States
- Joe Dimaggio Children'S Hospital/memorial Healthcare System
Hollywood, Florida, United States
- Children'S Healthcare of Atlanta
Atlanta, Georgia, United States
- Advocate Children'S Hospital
Oak Lawn, Illinois, United States
- Riley Hospital for Children
Indianapolis, Indiana, United States
- Boston Children'S Hospital
Boston, Massachusetts, United States
- University of Michigan
Ann Arbor, Michigan, United States
- Children'S Hospital of Michigan
Detroit, Michigan, United States
- Washington University School of Medicine
St Louis, Missouri, United States
- Mount Sinai Medical Center
New York, New York, United States
- Cincinnati Children'S Hospital
Cincinnati, Ohio, United States
- Nationwide Children'S Hospital
Columbus, Ohio, United States
- Children'S Hospital of Philadelphia
Philadelphia, Pennsylvania, United States
- Upmc Children'S Hospital of Pittsburgh
Pittsburgh, Pennsylvania, United States
- Medical University of South Carolina
Charleston, South Carolina, United States
- Medical City Dallas Hospital
Dallas, Texas, United States
- Texas Children'S Hospital
Houston, Texas, United States
- Primary Children'S Hospital
Salt Lake City, Utah, United States
- University of Virginia
Charlottesville, Virginia, United States
- Seattle Children'S Hospital
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 12 Mar 2021
- Primary completion
- 31 Mar 2027
- Completion
- 31 Mar 2032
- Last update posted
- 7 May 2025
- Registered enrollment
- 250
- Registry id
- NCT04591392
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.